Your browser doesn't support javascript.
loading
Real-world analysis of teclistamab in 123 RRMM patients from Germany.
Riedhammer, C; Bassermann, F; Besemer, B; Bewarder, M; Brunner, F; Carpinteiro, A; Einsele, H; Faltin, J; Frenking, J; Gezer, D; Goldman-Mazur, S; Hänel, M; Hoegner, M; Kortuem, K M; Krönke, J; Kull, M; Leitner, T; Mann, C; Mecklenbrauck, R; Merz, M; Morgner, A; Nogai, A; Raab, M S; Teipel, R; Wäsch, R; Rasche, L.
Afiliação
  • Riedhammer C; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Bassermann F; Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, Germany.
  • Besemer B; Department of Hematology, Oncology, and Immunology, University Hospital of Tübingen, Tübingen, Germany.
  • Bewarder M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University Medical Center, Homburg, Germany.
  • Brunner F; Department of Internal Medicine IV, University Hospital of Halle, Halle, Germany.
  • Carpinteiro A; Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, Germany.
  • Einsele H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Faltin J; Department of Hematology and Stem Cell Transplantation, Helios-Klinik Berlin Buch, Berlin, Germany.
  • Frenking J; Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
  • Gezer D; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Goldman-Mazur S; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
  • Hänel M; Department of Hematology, Cell therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany.
  • Hoegner M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Kortuem KM; Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, Germany.
  • Krönke J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Kull M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Leitner T; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Mann C; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Mecklenbrauck R; Department of Hematology, Oncology and Immunology, University Hospital of Gießen and Marburg, Marburg, Germany.
  • Merz M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School, Hannover, Germany.
  • Morgner A; Department of Hematology, Cell therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany.
  • Nogai A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Raab MS; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Teipel R; Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
  • Wäsch R; Department of Internal Medicine I, University Hospital of Dresden, Dresden, Germany.
  • Rasche L; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Leukemia ; 38(2): 365-371, 2024 02.
Article em En | MEDLINE | ID: mdl-38245601
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Neoplasias de Plasmócitos / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Leukemia Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Neoplasias de Plasmócitos / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Leukemia Ano de publicação: 2024 Tipo de documento: Article